Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
68Ga labeled Claudin 18.2 contrast agent combined with PET/CT for gastric or gastroesophageal junction
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| dose escalation | Experimental | subgroups mass does escalation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| [68Ga]Ga-NODAGA-SNA014 | Drug | Perform whole-body PET/CT scans on the subjects at 30 minutes (± 5 minutes), 60 minutes (± 10 minutes), 120 minutes (± 20 minutes), and 240 minutes (± 30 minutes) after administration. Among them, PET scanning can be performed on 1-2 subjects in a certain dose group or each dose group for 30-60 minutes. Among the four CT scans, one CT scan is a conventional low-dose CT scan (120mA), and the remaining three are extremely low-dose CT scans (10-20mA). The main researchers and nuclear medicine physicians can decide whether to change the subsequent image acquisition time and duration of the subjects based on the image information obtained from the enrolled subjects. |
| Measure | Description | Time Frame |
|---|---|---|
| Biological distribution characteristics | Evaluate the biological distribution characteristics of important organs in the subjects.
| 1week |
| Safety tolerance characteristics | AE/SAE/SUSAR | hrough study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Metabolic Dynamics Evaluation and Radiation Dose | Detect the radiation dose of whole blood and serum of the subjects, and calculate the absorbed dose of important organs | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Exploring the targeting ability of CLDN18.2 | Correlation analysis between PET/CT imaging features of target lesions (SUVmax, SUV mean, target to body ratio, etc.) and CLDN18.2IHC expression level (if any) | 1month |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Miao liyan Chief Pharmacist, doctorate | Contact | 0512-679-72858 | miaolysuzhou@163.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Jiangsu | Province | 215000 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|